LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.84 | 84.90 | 4190 | 4003 | 1.0467 | 1.0165 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.55 | 84.90 | 184 | 4287 | 0.0429 | 0.1465 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.55 | 84.90 | 3333 | 4287 | 0.7773 | 0.9129 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.55 | 84.90 | 330 | 4287 | 0.0770 | 0.2712 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.55 | 84.90 | 4526 | 4287 | 1.0555 | 1.0192 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.25 | 84.90 | 221 | 4539 | 0.0487 | 0.1814 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.25 | 84.90 | 3650 | 4539 | 0.8040 | 0.9254 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.25 | 84.90 | 339 | 4539 | 0.0747 | 0.2728 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.25 | 84.90 | 4870 | 4539 | 1.0727 | 1.0246 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.95 | 84.90 | 246 | 4952 | 0.0497 | 0.1988 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.95 | 84.90 | 3860 | 4952 | 0.7794 | 0.9168 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.95 | 84.90 | 397 | 4952 | 0.0802 | 0.3008 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 46.95 | 84.90 | 5250 | 4952 | 1.0601 | 1.0200 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 48.65 | 84.90 | 219 | 5328 | 0.0411 | 0.1720 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 48.65 | 84.90 | 4184 | 5328 | 0.7852 | 0.9206 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 48.65 | 84.90 | 412 | 5328 | 0.0773 | 0.3028 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 48.65 | 84.90 | 5607 | 5328 | 1.0522 | 1.0171 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 50.36 | 84.90 | 289 | 5651 | 0.0511 | 0.2242 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 50.36 | 84.90 | 4391 | 5651 | 0.7770 | 0.9184 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 50.36 | 84.90 | 471 | 5651 | 0.0833 | 0.3270 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 50.36 | 84.90 | 5868 | 5651 | 1.0384 | 1.0125 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 52.06 | 84.90 | 269 | 5990 | 0.0449 | 0.2066 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 52.06 | 84.90 | 4666 | 5990 | 0.7789 | 0.9202 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 52.06 | 84.90 | 484 | 5990 | 0.0808 | 0.3277 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 52.06 | 84.90 | 6250 | 5990 | 1.0433 | 1.0138 | MN20160318_Q02 | I17 |